Veralto R&D Spending Growth & History (VLTO)
Veralto's r&d spending was $266.0M for fiscal 2025.
View full Veralto company overviewVeralto annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $266.0M | $13.0M | +5.14% |
| 2024 | 2024-12-31 | $253.0M | $28.0M | +12.44% |
| 2023 | 2023-12-31 | $225.0M | $8.0M | +3.69% |
| 2022 | 2022-12-31 | $217.0M | −$27.0M | −11.07% |
| 2021 | 2021-12-31 | $244.0M | — | — |
Veralto quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $73.0M | $6.0M | +8.96% |
| Q1 2026 | 2026-04-03 | $68.0M | $4.0M | +6.25% |
| Q4 2025 | 2025-12-31 | $68.0M | −$1.0M | −1.45% |
| Q3 2025 | 2025-10-03 | $67.0M | $4.0M | +6.35% |
| Q2 2025 | 2025-07-04 | $67.0M | $6.0M | +9.84% |
| Q1 2025 | 2025-04-04 | $64.0M | $4.0M | +6.67% |
| Q4 2024 | 2024-12-31 | $69.0M | $12.0M | +21.05% |
| Q3 2024 | 2024-09-27 | $63.0M | $8.0M | +14.55% |
| Q2 2024 | 2024-06-28 | $61.0M | $4.0M | +7.02% |
| Q1 2024 | 2024-03-29 | $60.0M | $4.0M | +7.14% |
| Q4 2023 | 2023-12-31 | $57.0M | — | — |
| Q3 2023 | 2023-09-29 | $55.0M | $3.0M | +5.77% |
| Q2 2023 | 2023-06-30 | $57.0M | — | — |
| Q1 2023 | 2023-03-31 | $56.0M | — | — |
| Q3 2022 | 2022-09-30 | $52.0M | — | — |
Veralto r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Veralto's r&d spending increased from $244.0M to $266.0M, a change of $22.0M. The latest reported quarter, Q2 2026, shows $73.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Veralto source filings ↗